These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 15251109)

  • 1. After menopause: novel marker helps to identify women at risk for heart disease.
    Lewis SL
    J Fam Pract; 2004 Jul; Suppl():S18-24. PubMed ID: 15251109
    [No Abstract]   [Full Text] [Related]  

  • 2. Hormone replacement therapy and cardioprotection: a new dawn? A statement of the Study Group on Cardiovascular Disease in Women of the Italian Society of Cardiology on hormone replacement therapy in postmenopausal women.
    Rosano GM; Maffei S; Andreassi MG; Vitale C; Vassalle C; Gambacciani M; Stramba-Badiale M; Mercuro G
    J Cardiovasc Med (Hagerstown); 2009 Jan; 10(1):85-92. PubMed ID: 19145119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raising awareness of women and heart disease--women's hearts are different.
    Herrmann C
    Crit Care Nurs Clin North Am; 2008 Sep; 20(3):251-63. PubMed ID: 18644507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guidelines update on the prevention of heart disease in women.
    Caboral MF; King WV; Goolsby MJ
    J Am Acad Nurse Pract; 2008 Apr; 20(4):191-3. PubMed ID: 18387015
    [No Abstract]   [Full Text] [Related]  

  • 5. Menopause. A flash of concern.
    Wingert P
    Newsweek; 2007 Apr; 149(16):16. PubMed ID: 17477154
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of HMR 3339, a novel selective estrogen receptor modulator, on C-reactive protein levels in healthy postmenopausal women.
    Vogelvang TE; Mijatovic V; Kenemans P; Schalkwijk CG; van der Mooren MJ
    Am J Cardiol; 2004 Nov; 94(9):1205-8. PubMed ID: 15518626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Menopause: choices for women.
    Kroon V; Boyd L
    Aust Nurs J; 2001 Feb; 8(7):suppl 1-4. PubMed ID: 11894570
    [No Abstract]   [Full Text] [Related]  

  • 8. Women and heart disease.
    Stuenkel CA
    Med Sect Proc; 1994; ():203-15. PubMed ID: 7659713
    [No Abstract]   [Full Text] [Related]  

  • 9. Women and heart disease: what's new?
    Cheek D; Sherrod M; Tester J
    Nursing; 2007; 37 Suppl Cardiac():8-13. PubMed ID: 18046200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Women & heart disease: What's new?
    Cheek D; Sherrod M; Tester J
    Nursing; 2008 Jan; 38(1):36-41; quiz 42. PubMed ID: 18160890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone therapy for younger postmenopausal women: how can we make sense out of the evidence?
    Salpeter S
    Climacteric; 2005 Dec; 8(4):307-10. PubMed ID: 16390764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decisions on women's health: menopause and hormone replacement therapy.
    Visser A
    Patient Educ Couns; 2004 May; 53(2):119. PubMed ID: 15140449
    [No Abstract]   [Full Text] [Related]  

  • 13. Genetic variation in estrogen receptor, C-reactive protein and fibrinogen does not predict the plasma levels of inflammation markers after longterm hormone replacement therapy.
    de Maat MP; Madsen JS; Langdahl B; Bladbjerg EM; Tofteng CL; Abrahamsen B; Rejnmark L; Brixen K; Christensen K; Jespersen J; Kristensen SR
    Thromb Haemost; 2007 Feb; 97(2):234-9. PubMed ID: 17264952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen-plus-progestin use and mammographic density in postmenopausal women: Women's Health Initiative randomized trial.
    McTiernan A; Martin CF; Peck JD; Aragaki AK; Chlebowski RT; Pisano ED; Wang CY; Brunner RL; Johnson KC; Manson JE; Lewis CE; Kotchen JM; Hulka BS;
    J Natl Cancer Inst; 2005 Sep; 97(18):1366-76. PubMed ID: 16174858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
    Banks E; Canfell K
    Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health risks after cessation of postmenopausal hormone therapy.
    Pines A; Sturdee D; Birkhäuser M;
    Climacteric; 2008 Jun; 11(3):179-80. PubMed ID: 18568782
    [No Abstract]   [Full Text] [Related]  

  • 17. The impact of the Women's Health Initiative on discontinuation of postmenopausal hormone therapy: the Minnesota Heart Survey (2000-2002).
    Barber CA; Margolis K; Luepker RV; Arnett DK
    J Womens Health (Larchmt); 2004 Nov; 13(9):975-85. PubMed ID: 15665654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormone in the hot seat.
    Mandavilli A
    Nat Med; 2006 Jan; 12(1):8-9. PubMed ID: 16397539
    [No Abstract]   [Full Text] [Related]  

  • 19. Updated practical recommendations for hormone replacement therapy in the peri- and postmenopause.
    Birkhäuser MH; Panay N; Archer DF; Barlow D; Burger H; Gambacciani M; Goldstein S; Pinkerton JA; Sturdee DW
    Climacteric; 2008 Apr; 11(2):108-23. PubMed ID: 18365854
    [No Abstract]   [Full Text] [Related]  

  • 20. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.